Chairman of the Board of Directors of UCB S.A. (member of the Board since 2005, Chairman since 2012). Member of the Board of Lonza Group Ltd. (since 2006), and member of various board advisory committees. Board member of Vienna, Science, Research and Technology Foundation (since 2002), board member of Project Hope (since 2002) and member of the Circle of Patrons of INSEAD Business School (since 2000). Previous functions and activities: - Member of the Board of Alcon, Inc. 2007-2010, until it was acquired by Novartis. - Member of the Board of OMV AG, 2002-2009. - Member of the Board of Bank Austria AG, 1998-2006, until it was acquired by Unicredit. - Member of the U.S. – Egypt President’s Council, Washington, 1999-2004. - Member of the Board of the European Federation of the Pharmaceutical Industry (1995-1997 and 2000-2002). - Chairman of the International Executive Committee of the Pharmaceutical Research Manufacturers of America. - Chairman of the Europe Committee of the Pharmaceutical Research Manufacturers of America. - He joined Eli Lilly & Company in 1972 as a sales representative. He retired in 2004 as Executive Vicepresident of Global Pharmaceutical Operations. He held directorship positions in the US, Europe, Middle East, Asia and Latin America. As well as Executive Vice President from 1997 to 2004, he was also President of Lilly International, 1993-1997 and President of Lilly Intercontinental, 1997-1999. Gerhard Mayr has a degree in Chemical Engineering (Dipl.Ing.chem.ETH) from the Swiss Federal Institute of Technology (1969), and an MBA from the Stanford Graduate School of Business (1972). He was awarded the Grand Decoration of Honour in Silver for services to the Republic of Austria and the Decoration of Honour in Gold for services to the State and City of Vienna. He has also been awarded honours from the State of Indiana and the city of Indianapolis.

 Active Ingredient, Therapeutic Area or Country filters, Dermatologicals, Nervous system